Skip to Content
Merck
  • Impact of multidimensional interventions on quality of life and depression among older adults in a primary care setting in Brazil: a quasi-experimental study.

Impact of multidimensional interventions on quality of life and depression among older adults in a primary care setting in Brazil: a quasi-experimental study.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) (2019-12-12)
Bruno A da S Dantas, Jessica M A de Miranda, Anna C V Cavalcante, Gislani A da S Toscano, Larissa S S Torres, Simone C de O Rossignolo, Thaiza T X Nobre, Eulália M C Maia, Francisco A N de Miranda, Gilson de V Torres
ABSTRACT

To evaluate the impact of multidimensional interventions on quality of life (QoL) and depressive symptoms in Brazilian older adults living in the community. Longitudinal, quasi-experimental study of older adults receiving conventional primary health care (PHC). The interventions were designed in response to a first round of data collection and validated through pilot testing in groups of older adults from another community. The validated interventions were then applied to an intervention group (IG). To measure their effect, we used the Medical Outcomes Short-Form Health Survey (SF-36) quality of life scale and the Geriatric Depression Scale (GDS-30). The sample comprised 118 participants. IG participants exhibited significant improvement in several QoL domains (SF-36): mental health (p = 0.010), general health perceptions (p = 0.016), and physical functioning (p = 0.045). No such improvement occurred in controls (p > 0.050). The prevalence of depression (GDS-30) fell from 36.7 to 23.3% in the IG, despite no significant difference (p = 0.272). Controls also reported a reduction in depressive symptoms, but only from 44.8 to 41.4% (p = 0.112). This multidimensional intervention was associated with significant improvement in mental health, general health perceptions, and physical functioning in a sample of Brazilian older adults. RBR-92dbtx.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ethenesulfonyl fluoride, 95%